*Some Market data delayed by 15 mins.

Viridian Therapeutics, Inc. Common Stock

Symbol: VRDN (NASDAQ)
14.68 ▼ (-3.67%) -0.560

Company Description:
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Key Stats
  • Today's Open: $15.24
  • Today's High: $15.84
  • Today's Low: $14.03
  • Today's Volume: 1.01M
  • Yesterday Close: $15.24
  • Yesterday High: $16.075
  • Yesterday Low: $15.055
  • Yesterday Volume: 1.11M
  • Last Min Volume: 50
  • Last Min High: $14.68
  • Last Min Low: $14.68
  • Last Min VWAP: $14.68
Company Profile
  • Name: Viridian Therapeutics, Inc. Common Stock
  • Website: https://www.viridiantherapeutics.com
  • Listed Date: 2014-06-18
  • Location: WALTHAM, MA
  • Market Status: Active
  • CIK Number: 0001590750
  • SIC Code: 8071
  • SIC description: SERVICES-MEDICAL LABORATORIES
  • Market Cap: $923.51M
  • Round Lot: 100
  • Outstanding Shares: 63.82M
  • Asset Type: CS
RECENT FILINGS FOR VRDN
Filing DateFiling TypeFormat
2024-07-158-KView
2024-06-284View
2024-06-284View
2024-06-284View
2024-06-284View
2024-06-284View
2024-06-208-KView
2024-06-10DEFA14AView
2024-05-0810-QView
2024-05-088-KView
2024-04-26ARSView
2024-04-26DEFA14AView
2024-04-26DEF 14AView
2024-04-168-KView
2024-04-01SC 13D/AView
2024-04-014View
2024-02-28S-8View
2024-02-2710-KView
2024-02-278-KView
2024-02-14SC 13G/AView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.